Artificial Aortic Valve
Find comprehensive information on Artificial Aortic Valve, also known as Prosthetic Aortic Valve or Aortic Valve Replacement. This resource covers clinical documentation, medical coding, and healthcare aspects related to the diagnosis of an Artificial Aortic Valve. Learn about diagnosis codes, procedural terminology, and relevant clinical information for accurate and efficient medical record keeping. Explore essential details for healthcare professionals, including coding guidelines and best practices for documenting Artificial Aortic Valve conditions.
A mechanical or tissue valve surgically implanted to replace a diseased aortic valve.
Heart murmur, shortness of breath, chest pain, dizziness, fainting, fatigue.
Hospital cardiac surgery units, outpatient cardiology clinics.
ICD-10 Code Families
Complete code families applicable to Z95.2
When to use each related code
| Description | When to use |
|---|---|
| Artificial aortic valve | Use for surgically replaced aortic valve with prosthetic valve. Code type of valve. |
| Aortic valve stenosis | Narrowing of aortic valve, obstructing blood flow. Specify cause (congenital, rheumatic, degenerative). |
| Aortic valve regurgitation | Aortic valve leaking, causing backflow of blood. Specify cause (e.g., endocarditis, bicuspid valve). |
Best-practice checklist
- ✓Document type of aortic valve replacement (mechanical, bioprosthetic, etc.)
- ✓Specify the valve size and manufacturer
- ✓Record pre-operative indications for valve replacement
- ✓Document intraoperative findings and procedural details
- ✓Note post-operative function of the artificial valve
Common pitfalls to avoid
Coding lacks specificity regarding the type of artificial aortic valve (mechanical, bioprosthetic, etc.), impacting DRG assignment and reimbursement.
Missing documentation of the underlying cause for aortic valve replacement (e.g., stenosis, regurgitation) can lead to coding errors and compliance issues.
Incorrect coding of the specific aortic valve replacement procedure (TAVR, open surgery) can affect quality reporting and payment.
Best-practice tips
- 01Document valve type, size, and location for accurate coding (ICD-10-PCS).
- 02Specify if replacement is bioprosthetic or mechanical for proper reimbursement.
- 03Capture pre-op indications, intra-op details, and post-op complications.
- 04Query physician for clarification if documentation is unclear or incomplete.
- 05Regularly audit Aortic Valve Replacement documentation for compliance and CDI.
Step-by-step checklist
- 1
Verify aortic valve replacement type (mechanical vs bioprosthetic).
- 2
Confirm indication for AVR documented (e.g., stenosis, regurgitation).
- 3
Check echocardiogram report for valve function and gradients.
- 4
Document patient education regarding anticoagulation if applicable.
Ready-to-paste narrative
Patient presents for follow-up evaluation of their artificial aortic valve. The patient's aortic valve replacement, a bioprosthetic valve or mechanical valve depending on previous documentation, was placed on [Date of surgery]. Current symptoms include [List current symptoms, e.g., dyspnea on exertion, chest pain, palpitations, or asymptomatic]. Physical examination reveals [Document heart rate, rhythm, presence or absence of murmurs, and other relevant cardiovascular findings]. Echocardiogram performed on [Date of echocardiogram] demonstrates [Specific findings, e.g., mean pressure gradient, valve function, presence or absence of paravalvular leak, left ventricular ejection fraction]. Patient's international normalized ratio (INR) is [INR value if applicable] and they are currently prescribed [Medications, e.g., warfarin, aspirin, antiplatelet therapy]. The patient's condition is assessed as stable, improved, or worsening depending on clinical presentation. Plan includes continued monitoring of valve function with repeat echocardiography in [Timeframe], optimization of anticoagulation therapy if applicable, and patient education regarding signs and symptoms of valve dysfunction. Discussion regarding potential complications, including thromboembolism, endocarditis, and structural valve deterioration, was reviewed with the patient. Follow-up appointment scheduled in [Timeframe]. Diagnoses include: Aortic valve prosthesis, status post aortic valve replacement.
Common questions and answers
What are the key postoperative management considerations for patients with a bioprosthetic aortic valve replacement?+
Postoperative management of patients with a bioprosthetic aortic valve replacement focuses on hemodynamic stability, anticoagulation management, infection prophylaxis, and monitoring for complications. Early ambulation and pulmonary hygiene are crucial to prevent thromboembolic events and respiratory complications. Anticoagulation therapy, typically with warfarin for a limited duration (e.g., 3 months) is often prescribed depending on individual patient risk factors such as atrial fibrillation. Lifelong antibiotic prophylaxis for infective endocarditis is generally not recommended for bioprosthetic valves unless the patient has other risk factors like previous endocarditis or a prosthetic joint. Regular follow-up with echocardiography is essential to assess valve function and detect potential complications like paravalvular leak or structural valve deterioration. Explore how our comprehensive platform can assist in streamlining postoperative care pathways for optimal patient outcomes.
How do I differentiate between structural valve deterioration (SVD) and prosthetic valve endocarditis (PVE) in a patient with a mechanical aortic valve replacement?+
Differentiating between structural valve deterioration (SVD) and prosthetic valve endocarditis (PVE) in a patient with a mechanical aortic valve replacement can be challenging, as both can present with similar symptoms such as heart failure or new-onset murmur. SVD typically manifests as stenosis or regurgitation due to wear and tear or pannus formation, often observed through echocardiography showing changes in valve leaflet motion or increased transvalvular gradients. PVE, on the other hand, is an infection of the valve and surrounding tissue, potentially accompanied by fever, leukocytosis, and positive blood cultures. Transesophageal echocardiography (TEE) is often crucial for detecting vegetations or abscesses suggestive of PVE. Consider implementing a multidisciplinary approach involving cardiology, infectious disease, and cardiac surgery to accurately diagnose and manage these complex cases. Learn more about the latest diagnostic criteria for PVE and SVD to enhance your clinical decision-making.
What are the long-term anticoagulation recommendations for patients after a mechanical aortic valve replacement, considering factors like age and stroke risk?+
Long-term anticoagulation is crucial for patients after a mechanical aortic valve replacement to prevent thromboembolic complications. Warfarin, a vitamin K antagonist, remains the standard of care, targeting an international normalized ratio (INR) typically between 2.0 and 3.0 depending on the specific valve type and individual patient characteristics. For patients at high risk of bleeding, a lower INR target (e.g., 1.5-2.5) may be considered. Direct oral anticoagulants (DOACs) are generally not recommended as first-line therapy for mechanical aortic valves due to limited evidence and potential increased thromboembolic risk compared to warfarin. Regular INR monitoring and patient education on anticoagulation management are essential. Factors like age, prior stroke history, and comorbidities influence the intensity and duration of anticoagulation, and personalized strategies are crucial for optimizing patient outcomes. Explore our resources on evidence-based anticoagulation guidelines for patients with mechanical heart valves.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.